Who owns NUVECTIS PHARMA INC?
- Ticker: NVCT
- CUSIP Number: 67080t108
Tip: Access positions for across all investors
Analyze quarterly positions in Nuvectis Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nuvectis Pharma stock
Who bought or sold NUVECTIS PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 846k | $6.4M | 21% | Dec 2025 |
|
| BlackRock | 783k | $5.9M | 14% | Dec 2025 |
|
| Iridian Asset Management | 586k | $4.4M | 45% | Dec 2025 |
|
| Baldwin Brothers | 390k | $2.9M | 11% | Dec 2025 |
|
| Geode Capital Management | 364k | $2.7M | 12% | Dec 2025 |
|
| Susquehanna International | 195k | $1.5M | 92% | Dec 2025 |
|
| State Street Corporation | 155k | $1.2M | 13% | Dec 2025 |
|
| Northern Trust | 116k | $879k | 9% | Dec 2025 |
|
| Citadel Advisors | 87k | $526k | 285% | Sep 2025 |
|
| Oppenheimer & Co | 74k | $555k | 7% | Dec 2025 |
|
| Paul Kendrigan | 59k | $446k | 0% | Dec 2025 |
|
| Charles Schwab Investment Management | 44k | $332k | 16% | Dec 2025 |
|
| Bank of New York Mellon | 32k | $239k | 13% | Dec 2025 |
|
| Royal Bank of Canada | 31k | $153k | -1% | Sep 2025 |
|
| Goldman Sachs Group | 27k | $200k | -41% | Dec 2025 |
|
| Barclays | 24k | $183k | 31% | Dec 2025 |
|
| Austin Wealth Management | 20k | $178k | 0% | Dec 2025 |
|
| Two Sigma Investments | 18k | $111k | 2% | Sep 2025 |
|
| Jane Street | 18k | $135k | -32% | Dec 2025 |
|
| Wells Fargo & Company | 17k | $128k | 114% | Dec 2025 |
|
| Nuveen | 17k | $127k | 0% | Dec 2025 |
|
| Edmond De Rothschild Holding | 15k | $115k | 0% | Dec 2025 |
|
| Atlantic Trust | 15k | $110k | 100% | Dec 2025 |
|
| Avalon Trust | 14k | $106k | 40% | Dec 2025 |
|
| Nations Financial Group | 13k | $98k | 0% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 13k | $96k | 3671% | Dec 2025 |
|
| Rhumbline Advisers | 8.4k | $64k | -26% | Dec 2025 |
|
| UBS Group | 8.4k | $63k | -67% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 7.2k | $54k | 20% | Dec 2025 |
|
| Jpmorgan Chase & Co | 5.3k | $32k | 100% | Sep 2025 |
|
| New York State Common Retirement Fund | 5.0k | $38k | 0% | Dec 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 3.8k | $29k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.5k | $27k | 27% | Dec 2025 |
|
| Nbc Securities | 3.0k | $23k | 100% | Dec 2025 |
|
| Legal & General Group | 1.4k | $11k | 0% | Dec 2025 |
|
| Tower Research Capital | 1.4k | $11k | -63% | Dec 2025 |
|
| Summit Investment Advisors | 1.3k | $9.9k | 0% | Dec 2025 |
|
| Russell Investments | 1.1k | $8.0k | 0% | Dec 2025 |
|
| California State Teachers Retirement System | 953.00 | $7.2k | 19% | Dec 2025 |
|
| Amalgamated Bank | 486.00 | $4.0k | 10% | Dec 2025 |
|
| Spire Wealth Management | 300.00 | $2.3k | 100% | Dec 2025 |
|
| GAMMA Investing | 171.00 | $1.3k | 94% | Dec 2025 |
|
| Steward Partners Investment Advisory | 100.00 | $755.000000 | 0% | Dec 2025 |
|
| Sterling Capital Management | 84.00 | $633.998400 | 171% | Dec 2025 |
|
| FMR | 67.00 | $402.998300 | 1240% | Sep 2025 |
|
| CWM | 33.00 | $0 | -6% | Dec 2025 |
|
| Pnc Financial Services | 23.00 | $173.999600 | -58% | Dec 2025 |
|
Who sold out of Nuvectis Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Sep 2025 | 43k | $258k |
| Millennium Management | Jun 2025 | 31k | $233k |
| GSA Capital Partners | Sep 2025 | 24k | $141k |
| XTX Topco | Sep 2025 | 15k | $90k |
| Marshall Wace | Sep 2025 | 11k | $64k |
| EverSource Wealth Advisors | Sep 2025 | 76.00 | $457.998800 |
| SRS Capital Advisors | Sep 2025 | 38.00 | $228.999400 |